Statins cut stroke risk after radiation therapy for cancer

By American Heart Association News

AndrewSoundarajan/iStock, Getty Images
(AndrewSoundarajan/iStock, Getty Images)

Cancer patients who took cholesterol-lowering statin medication after radiation therapy to the chest, neck or head cut their risk of a stroke by nearly a third, a new study shows.

The study, published Wednesday in the Journal of the American Heart Association, is the first large-scale look at the effects of statins in people who had radiation therapy.

More than half of cancer patients are treated with such therapy. Radiation kills cancer cells and shrinks tumors, but it also affects nearby cells, causing side effects that include scarring or thickening of arteries.

Over time that can lead to blockages that cause heart attack and stroke. Cardiovascular disease, the study noted, is the leading cause of illness and death among cancer survivors.

Statins have anti-inflammatory properties, and many studies have shown they reduce the risk of vascular disease, study author Dr. Negar Mousavi, of McGill University Health Center in Montreal, said in a news release. Statins reduce the formation of plaque that blocks blood vessels.

In the new study, researchers found the use of statins was associated with a 32% reduction in stroke.

Researchers also saw "a strong trend" toward an overall reduction in having or dying from a heart attack or stroke.

The study included 5,718 heart attack and stroke survivors over age 65 who had undergone radiation therapy to the chest, head or neck between 2000 and 2011. Most were taking statins.

The authors said more research is needed to explore the role of statins after radiation therapy in broader populations and to establish guidelines on how to manage radiation-induced vascular disease.

If you have questions or comments about this story, please email [email protected].

American Heart Association News Stories

American Heart Association News covers heart disease, stroke and related health issues. Not all views expressed in American Heart Association News stories reflect the official position of the American Heart Association. Statements, conclusions, accuracy and reliability of studies published in American Heart Association scientific journals or presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect the American Heart Association’s official guidance, policies or positions.

Copyright is owned or held by the American Heart Association, Inc., and all rights are reserved. Permission is granted, at no cost and without need for further request, for individuals, media outlets, and non-commercial education and awareness efforts to link to, quote, excerpt from or reprint these stories in any medium as long as no text is altered and proper attribution is made to American Heart Association News.

Other uses, including educational products or services sold for profit, must comply with the American Heart Association’s Copyright Permission Guidelines. See full terms of use. These stories may not be used to promote or endorse a commercial product or service.

HEALTH CARE DISCLAIMER: This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. If you are in the United States and experiencing a medical emergency, call 911 or call for emergency medical help immediately.